Scientists have developed a simple DNA blood test that can predict how well patients with breast cancer will respond to treatment.
More than 2 million people globally each year are diagnosed with the disease, which is the world’s most prevalent cancer. Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
Now researchers have designed a liquid biopsy that tells doctors how likely a patient is to respond to a specific treatment, even before it begins. The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the
Continue Reading on The Guardian
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.